Orthopaedics was the largest of Stryker Corp’s 3 reported lines in fiscal 2015, at $4.22B — 42% of $9.95B.
| Statement Business Segments | FY 2008 | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 |
|---|---|---|---|---|---|---|---|---|
| United States | — | — | — | — | ||||
| Orthopaedics | — | — | $4.15B | $4.22B | ||||
| Ortho | $3.82B | $3.95B | — | — | ||||
| Reconstructive | — | — | — | — | ||||
| Medsurg | $3.27B | $3.41B | $3.78B | $3.90B | ||||
| Neurotechnology & Spine | $1.57B | $1.66B | $1.74B | $1.83B | ||||
| Europe, Middle East, Africa | — | — | — | — | ||||
| Other European Countries | — | — | — | — | ||||
| Asia Pacific | — | — | — | — | ||||
| Other Foreign Countries | — | — | — | — | ||||
| Ireland | — | — | — | — | ||||
| Total | $8.66B | $9.02B | $9.68B | $9.95B |
In fiscal 2015, which ended December 31, 2015, the 3 segments Stryker Corp reported in this breakdown added up to $9.95B. That was up 2.8% from $9.68B in fiscal 2014. Orthopaedics was the largest segment, at $4.22B or 42.5% of the total, followed by Medsurg ($3.90B, 39.2%) and Neurotechnology & Spine ($1.83B, 18.4%). Together, the two largest segments made up 81.6% of this total.
Compared with fiscal 2014, Neurotechnology & Spine grew the fastest, rising 5.0% to $1.83B. Every sizeable segment reported in both years grew.
Orthopaedics was first reported as a separate segment in fiscal 2014. The table also keeps 8 segments that Stryker Corp no longer reports, so earlier years can still be read on their original basis; use "Show 8 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2008 to 2015, as reported in Stryker Corp's annual filings.
United States was the largest of Stryker Corp’s 4 reported lines in fiscal 2017, at $9.06B — 73% of $12.44B.
| Geography | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 |
|---|---|---|---|---|---|---|
| United States | $6.56B | $7.12B | $8.23B | $9.06B | ||
| Europe, Middle East, Africa | $1.37B | $1.27B | $1.44B | $1.57B | ||
| Europe, Middle East, & Africa | — | — | — | — | ||
| Asia Pacific | $1.37B | $1.25B | $1.33B | $1.41B | ||
| Other Foreign Countries | $378.00M | $312.00M | $333.00M | $405.00M | ||
| Total | $9.68B | $9.95B | $11.33B | $12.44B |
In fiscal 2017, which ended December 31, 2017, the 4 regions Stryker Corp reported in this breakdown added up to $12.44B. That was up 9.9% from $11.33B in fiscal 2016. United States was the largest region, at $9.06B or 72.8% of the total, followed by Europe, Middle East, Africa ($1.57B, 12.6%) and Asia Pacific ($1.41B, 11.4%). Together, the two largest regions made up 85.4% of this total.
Compared with fiscal 2016, Other Foreign Countries grew the fastest, rising 21.6% to $405.00M. Every sizeable region reported in both years grew. Over fiscal 2014 to 2017, revenue across these regions went from $9.68B to $12.44B, a compound annual growth rate of 8.8%. United States' share of the total rose from 67.8% to 72.8% over the same years.
The table also keeps 1 region that Stryker Corp no longer reports, so earlier years can still be read on their original basis; use "Show 1 discontinued" beneath the table to see them. This breakdown covers every fiscal year from 2012 to 2017, as reported in Stryker Corp's annual filings.
Stryker Corp (SYK) breaks its revenue down by segment and region. In fiscal 2015, its largest segment was Orthopaedics, with $4.22B or 42.5% of the total, followed by Medsurg at $3.90B (39.2%).
Orthopaedics was Stryker Corp's largest segment in fiscal 2015, with $4.22B in revenue, 42.5% of the $9.95B reported across its 3 segments.
United States was Stryker Corp's largest region in fiscal 2017, with $9.06B in revenue, 72.8% of the $12.44B reported across its 4 regions.
Of the Stryker Corp segments reported in both fiscal 2014 and fiscal 2015, and making up at least 2% of the total, Neurotechnology & Spine grew the fastest, rising 5.0% from $1.74B to $1.83B.
Every figure is taken from Stryker Corp's annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by segment covers fiscal 2008 to 2015. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.